volume 34 issue 1-2 pages 27-36

Early investigational agents for the treatment of rosacea: drugs in phase I and II clinical development

Shannon K. Moran 1
Summer C. Wong 1
Sarah L. Taylor 1
Steven R. Feldman 1
Publication typeJournal Article
Publication date2025-02-07
scimago Q1
wos Q1
SJR1.267
CiteScore8.3
Impact factor4.1
ISSN13543784, 17447658
Found 
Found 

Top-30

Journals

1
Expert Review of Clinical Pharmacology
1 publication, 50%
Journal of the European Academy of Dermatology and Venereology
1 publication, 50%
1

Publishers

1
Taylor & Francis
1 publication, 50%
Wiley
1 publication, 50%
1
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
2
Share
Cite this
GOST |
Cite this
GOST Copy
Moran S. K. et al. Early investigational agents for the treatment of rosacea: drugs in phase I and II clinical development // Expert Opinion on Investigational Drugs. 2025. Vol. 34. No. 1-2. pp. 27-36.
GOST all authors (up to 50) Copy
Moran S. K., Wong S. C., Taylor S. L., Feldman S. R. Early investigational agents for the treatment of rosacea: drugs in phase I and II clinical development // Expert Opinion on Investigational Drugs. 2025. Vol. 34. No. 1-2. pp. 27-36.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1080/13543784.2025.2463093
UR - https://www.tandfonline.com/doi/full/10.1080/13543784.2025.2463093
TI - Early investigational agents for the treatment of rosacea: drugs in phase I and II clinical development
T2 - Expert Opinion on Investigational Drugs
AU - Moran, Shannon K.
AU - Wong, Summer C.
AU - Taylor, Sarah L.
AU - Feldman, Steven R.
PY - 2025
DA - 2025/02/07
PB - Taylor & Francis
SP - 27-36
IS - 1-2
VL - 34
SN - 1354-3784
SN - 1744-7658
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2025_Moran,
author = {Shannon K. Moran and Summer C. Wong and Sarah L. Taylor and Steven R. Feldman},
title = {Early investigational agents for the treatment of rosacea: drugs in phase I and II clinical development},
journal = {Expert Opinion on Investigational Drugs},
year = {2025},
volume = {34},
publisher = {Taylor & Francis},
month = {feb},
url = {https://www.tandfonline.com/doi/full/10.1080/13543784.2025.2463093},
number = {1-2},
pages = {27--36},
doi = {10.1080/13543784.2025.2463093}
}
MLA
Cite this
MLA Copy
Moran, Shannon K., et al. “Early investigational agents for the treatment of rosacea: drugs in phase I and II clinical development.” Expert Opinion on Investigational Drugs, vol. 34, no. 1-2, Feb. 2025, pp. 27-36. https://www.tandfonline.com/doi/full/10.1080/13543784.2025.2463093.